Related articles - How to synthesize Zanubrutinib?
- Zanubrutinib is a drug that was shown to effectively treat cancer of B cells without causing severe excessive side effects.
- Jan 25，2024
|
| | Zanubrutinib Basic information |
| Product Name: | Zanubrutinib | | Synonyms: | Zanubrutinib;anubrutinib;BGB-3111(Zanubrutinib);The BTK inhibitor;Zanubrutinib (BGB-3111);BGB-3111;ZANUBRUTINIB;BGB 3111;BGB3111;(S)-7-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide;Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7S)- | | CAS: | 1691249-45-2 | | MF: | C27H29N5O3 | | MW: | 471.55 | | EINECS: | | | Product Categories: | API | | Mol File: | 1691249-45-2.mol |  |
| | Zanubrutinib Chemical Properties |
| Boiling point | 713.4±60.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:99.67(Max Conc. mg/mL);211.36(Max Conc. mM)
DMF:10.0(Max Conc. mg/mL);21.21(Max Conc. mM)
DMF:PBS (pH 7.2) (1:5):0.16(Max Conc. mg/mL);0.34(Max Conc. mM)
Ethanol:33.33(Max Conc. mg/mL);70.68(Max Conc. mM) | | form | A solid | | pka | 15.35±0.40(Predicted) |
| | Zanubrutinib Usage And Synthesis |
| Uses | Zanubrutinib is classified as a Bruton''s tyrosine kinase inhibitor. Zanubrutinib is a medication for the treatment of adults with mantle cell lymphoma. |
| | Zanubrutinib Preparation Products And Raw materials |
|